Debra A Peattie

Title: Debra A. Peattie: Innovator in FK506 Binding Protein Research

Introduction

Debra A. Peattie is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of molecular biology, particularly in the study of FK506 binding proteins. Her work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Debra A. Peattie holds a patent for the "Isolation of an M.sub.r 52,000 FK506 binding protein and molecular." This invention involves the isolation of an FK506 binding protein of mammalian origin, approximately 52,000 in size, using FK506 affinity chromatography. Additionally, she has developed a corresponding human cDNA of approximately 2.2 Kb, isolated by screening a human placenta cDNA library with a DNA probe that predicts a consensus amino acid sequence present in five FKBP12 sequences and in the human FKBP13 sequence. This patent highlights her innovative approach to molecular isolation techniques.

Career Highlights

Debra A. Peattie is currently associated with Vertex Pharmaceuticals, Inc., where she continues her research and development efforts. Her work at Vertex has allowed her to collaborate with leading scientists in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Debra has worked alongside notable colleagues, including David J. Livingston and Matthew W. Harding. These collaborations have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Debra A. Peattie is a distinguished inventor whose research on FK506 binding proteins has advanced our understanding of molecular biology. Her contributions continue to influence the field and inspire future innovations.